Back
UroGen Pharma Vs. Apogee Enterprises Industry Stock Comparison
Sell
23
URGN
UroGen Pharma
Last Price:
$11.02
Seasonality Move:
-4.35%
Sell
28
APOG
Apogee Enterprises
Last Price:
$52.54
Seasonality Move:
5.76%
Sell
23
UroGen Pharma (URGN)
is a Sell
Is UroGen Pharma a Buy, Sell or Hold?
-
The current UroGen Pharma [URGN] share price is $11.04. The Score for URGN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Apogee Enterprises (APOG)
is a Sell
Is Apogee Enterprises a Buy, Sell or Hold?
-
The current Apogee Enterprises [APOG] share price is $52.52. The Score for APOG is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
APOG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $11.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $52.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing selling pressure, which indicates risk of future bearish movement.
URGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 45.54 | Sell |
Chaikin Money Flow: | 72936 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.69 - 11.89) | Sell |
Bollinger Bands (100): | (11.37 - 13.59) | Sell |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.64 | Sell |
Relative Strength Index (14 RSI): | 11.6 | Sell |
Chaikin Money Flow: | -398167 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.86 - 81.36) | Sell |
Bollinger Bands (100): | (66.06 - 81.4) | Sell |
URGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.87 | Buy |
20-day SMA: | 11.03 | Buy |
50-day SMA: | 11.71 | Sell |
200-day SMA: | 13.66 | Sell |
8-day EMA: | 10.97 | Buy |
20-day EMA: | 11.13 | Sell |
50-day EMA: | 11.66 | Sell |
200-day EMA: | 13.18 | Sell |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.43 | Sell |
20-day SMA: | 71.9 | Sell |
50-day SMA: | 77.92 | Sell |
200-day SMA: | 67.99 | Sell |
8-day EMA: | 65.13 | Sell |
20-day EMA: | 70.76 | Sell |
50-day EMA: | 74.46 | Sell |
200-day EMA: | 68.5 | Sell |
UroGen Pharma Earnings Growth & URGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $2.30 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.35 per share, and a decrease next year of $0.76 per share.
UroGen Pharma Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |